Literature DB >> 27404684

Depression in heart failure: Can PHQ-9 help?

Kunal N Bhatt1, Andreas P Kalogeropoulos1, Sandra B Dunbar1, Javed Butler2, Vasiliki V Georgiopoulou3.   

Abstract

BACKGROUND: The Patient Health Questionnaire 9 (PHQ-9) is an effective tool for identification and grading of depression symptoms. Data on PHQ-9 utility for patients with heart failure (HF) are limited.
METHODS: We evaluated the severity of depression by PHQ-9 at baseline and its association with health care resource utilization (HCRU) rates and quality of life (QoL) in 308 outpatients enrolled in a prospective HF cohort study. Depression symptoms were stratified according to PHQ-9 score as minimal (0-4), mild (5-9), or moderate-to-severe (10-27).
RESULTS: Mean age of patients was 57±11years; 65% were men; 50% were white and 47% black; ejection fraction was 30±15%. Over 24±12months (total: 625person-years), there were 41 (13.3%) major clinical events (34 deaths, 5 transplants, 2 ventricular assist device implantations), 633 all-cause admissions (249 [39.3%] for HF), and 362 emergency department (ED) visits. Moderate-to-severe depressive symptoms were associated with 70% more all-cause admissions compared to patients without depressive symptoms and 2.5 times more HF-related admissions. However, less than 50% of patients with moderate-to-severe symptoms were on antidepressants. In adjusted analyses, even mild depressive symptoms were associated with 57% more all-cause admissions compared to patients without depressive symptoms and more than 2-fold higher rate of HF-related admissions. Depressive symptoms were not associated with ED visits. Increasing PHQ-9 score was associated with progressively worse QoL. PHQ-9 was not associated with major clinical events.
CONCLUSIONS: PHQ-9 effectively identifies HF patients at risk for increased HCRU and lower QoL. Interventions to reduce depression symptoms may help improve HF outcomes.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Depression; Heart failure; Hospitalization; Outcomes

Mesh:

Year:  2016        PMID: 27404684     DOI: 10.1016/j.ijcard.2016.07.057

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  14 in total

1.  Stress management interventions for adults with heart failure: Systematic review and meta-analysis.

Authors:  Emily C Gathright; Elena Salmoirago-Blotcher; Julie DeCosta; Marissa L Donahue; Melissa M Feulner; Dean G Cruess; Rena R Wing; Michael P Carey; Lori A J Scott-Sheldon
Journal:  Health Psychol       Date:  2021-09       Impact factor: 5.556

2.  The impact of antidepressants on depressive symptom severity, quality of life, morbidity, and mortality in heart failure: a systematic review.

Authors:  Rebecca Hedrick; Samuel Korouri; Emile Tadros; Tarneem Darwish; Veronica Cortez; Desiree Triay; Mia Pasini; Linda Olanisa; Nathalie Herrera; Sophia Hanna; Asher Kimchi; Michele Hamilton; Itai Danovitch; Waguih William IsHak
Journal:  Drugs Context       Date:  2020-07-29

3.  Effectiveness of a PRECEDE-based education intervention on quality of life in elderly patients with chronic heart failure.

Authors:  Qiong Wang; Lini Dong; Zaijin Jian; Xianghua Tang
Journal:  BMC Cardiovasc Disord       Date:  2017-10-16       Impact factor: 2.298

4.  Associations of mood symptoms with NYHA functional classes in angina pectoris patients: a cross-sectional study.

Authors:  Han Yin; Yuting Liu; Huan Ma; Guihao Liu; Lan Guo; Qingshan Geng
Journal:  BMC Psychiatry       Date:  2019-03-05       Impact factor: 3.630

5.  Personalized treatments for depressive symptoms in patients with advanced heart failure: A pragmatic randomized controlled trial.

Authors:  Waguih William IsHak; Samuel Korouri; Tarneem Darwish; Brigitte Vanle; Jonathan Dang; Gabriel Edwards; Jeanne T Black; Harriet Aronow; Asher Kimchi; Brennan Spiegel; Rebecca Hedrick; Robert Chernoff; Marcio A Diniz; James Mirocha; Vicki Manoukian; John Harold; Michael K Ong; Kenneth Wells; Michele Hamilton; Itai Danovitch
Journal:  PLoS One       Date:  2021-01-07       Impact factor: 3.240

6.  The potential of the inodilator levosimendan in maintaining quality of life in advanced heart failure.

Authors:  Markku S Nieminen; Cândida Fonseca; Dulce Brito; Gerhard Wikström
Journal:  Eur Heart J Suppl       Date:  2017-03-08       Impact factor: 1.803

7.  Combined Influence of Depression and Physical Frailty on Cognitive Impairment in Patients with Heart Failure.

Authors:  Jong Kyung Lee; Mi Hwa Won; Youn-Jung Son
Journal:  Int J Environ Res Public Health       Date:  2018-12-27       Impact factor: 3.390

Review 8.  Impact of non-cardiovascular comorbidities on the quality of life of patients with chronic heart failure: a scoping review.

Authors:  Josep Comín-Colet; Teresa Martín Lorenzo; Almudena González-Domínguez; Juan Oliva; Silvia Jiménez Merino
Journal:  Health Qual Life Outcomes       Date:  2020-10-07       Impact factor: 3.186

Review 9.  Prioritizing symptom management in the treatment of chronic heart failure.

Authors:  Aaron O Koshy; Elisha R Gallivan; Melanie McGinlay; Sam Straw; Michael Drozd; Anet G Toms; John Gierula; Richard M Cubbon; Mark T Kearney; Klaus K Witte
Journal:  ESC Heart Fail       Date:  2020-08-05

Review 10.  TaiChi and Qigong for Depressive Symptoms in Patients with Chronic Heart Failure: A Systematic Review with Meta-Analysis.

Authors:  Wei Jiang; Shaojun Liao; Xiankun Chen; Cecilia Stålsby Lundborg; Gaetano Marrone; Zehuai Wen; Weihui Lu
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-24       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.